↓ Skip to main content

Dove Medical Press

Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, July 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
27 Mendeley